Related Experiment Videos
[Results of PTCA following thrombolysis in acute myocardial infarct]
1II. Medizinische Klinik und Poliklinik Johannes-Gutenberg-Universität Mainz.
Insights
Thrombolytic therapy within 6 hours reduces myocardial infarction mortality. Percutaneous coronary angioplasty (PTCA) or bypass surgery offers the highest long-term survival rates for coronary artery disease.
Area of Science:
- Cardiology
- Interventional Cardiology
- Cardiovascular Surgery
Context:
- Acute transmural myocardial infarction presents significant mortality risks.
- Treatment strategies vary based on coronary angiography findings and disease extent.
Purpose:
- To outline evidence-based therapeutic recommendations for acute myocardial infarction and coronary artery disease.
- To compare the long-term survival rates associated with different treatment modalities.
Summary:
- Thrombolytic therapy is crucial within 6 hours for acute myocardial infarction.
- Conservative therapy suits stenosis <70%. Percutaneous coronary angioplasty (PTCA) is indicated for suitable lesions, occluded vessels, and high-grade stenosis with limited flow.
- Aortocoronary bypass surgery is recommended for multi-vessel disease, with both PTCA and bypass surgery demonstrating superior long-term survival.
Impact:
- Establishes treatment guidelines for acute myocardial infarction and coronary artery disease.
- Highlights the superior long-term survival benefits of revascularization procedures like PTCA and bypass surgery.
- Informs clinical decision-making for optimizing patient outcomes in cardiovascular interventions.
Abstract:
The mortality in acute transmural myocardial infarction can be reduced by thrombolytic therapy administered within 6 hours after onset of symptoms. In patients with coronary angiography proven stenosis of less than 70% conservative therapy is recommended. In patients with one vessel disease PTCA in patients with suitable lesions should be used. Further studies have to elucidate, if the angioplasty has to be performed in the acute stage or on an elective basis. PTCA is recommended in patients with occluded coronary vessels and in patients with high grade stenosis and limited coronary blood flow. In patients with multi vessel disease aortocoronary bypass surgery is recommended to reduce high mortality. Long-term results demonstrate, that patients in whom PTCA or coronary bypass surgery was performed demonstrated the highest survival rate.